Osaka, Japan

Maki Tokai

This inventor holds 2 USPTO granted patents. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2006-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maki Tokai. Retrieved from https://idiyas.com/inventor/maki-tokai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maki Tokai: Innovator in Pain Management

Introduction

Maki Tokai is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pain management through her innovative research and development. With a total of 2 patents, her work focuses on novel methods for treating pain and pruritis.

Latest Patents

Maki Tokai's latest patents include a method for treating pain or pruritis by administering a κ-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative. This method involves administering a pharmaceutically effective amount of a κ-opioid receptor agonist to a patient in need. Additionally, she has developed a compound or a salt thereof that features a specific formula with various substituents, aimed at enhancing the efficacy of pain treatment.

Career Highlights

Maki Tokai is currently employed at Santen Pharmaceutical Co., Ltd., where she continues to advance her research in pharmacology. Her work has garnered attention for its potential to improve patient outcomes in pain management.

Collaborations

Maki collaborates with notable colleagues, including Takahiro Honda and Masashi Niwa, who contribute to her research endeavors and help drive innovation in the field.

Conclusion

Maki Tokai's contributions to pain management through her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…